These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Interaction between gemfibrozil and warfarin: case report and review of the literature. Dixon DL; Williams VG Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425 [TBL] [Abstract][Full Text] [Related]
25. Simvastatin-induced myopathy in a patient treated for hypercholesterolemia. Morphological aspects. Wicher-Muniak E; Zmudka K; Dabroś W; Dudek D; Stachura J Pol J Pathol; 1997; 48(1):69-74. PubMed ID: 9200964 [TBL] [Abstract][Full Text] [Related]
26. The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Goldman JA; Fishman AB; Lee JE; Johnson RJ Arthritis Rheum; 1989 Mar; 32(3):358-9. PubMed ID: 2930608 [No Abstract] [Full Text] [Related]
27. Lovastatin-induced myopathy in a hypothyroid patient. Ahmad S J Fam Pract; 1995 Sep; 41(3):227-8. PubMed ID: 7650497 [No Abstract] [Full Text] [Related]
28. Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. van Puijenbroek EP; Du Buf-Vereijken PW; Spooren PF; van Doormaal JJ J Intern Med; 1996 Dec; 240(6):403-4. PubMed ID: 9010388 [TBL] [Abstract][Full Text] [Related]
31. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Chang JT; Staffa JA; Parks M; Green L Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925 [TBL] [Abstract][Full Text] [Related]
32. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
33. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates]. Chauvin M; Zupan M; Brechenmacher C Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389 [TBL] [Abstract][Full Text] [Related]
34. Outcomes in 45 patients with statin-associated myopathy. Hansen KE; Hildebrand JP; Ferguson EE; Stein JH Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427 [TBL] [Abstract][Full Text] [Related]
36. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia]. Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396 [TBL] [Abstract][Full Text] [Related]
37. Fish oil (omega-3 fatty acids) in treatment of hypertriglyceridemia. A practical approach for the primary care physician. Bays H; Lansing AM J Ky Med Assoc; 1994 Mar; 92(3):105-8. PubMed ID: 8035110 [TBL] [Abstract][Full Text] [Related]
38. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen. Marsà Carretero M; Alos Manrique C; Valles Callol JA Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671 [No Abstract] [Full Text] [Related]
39. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. Jones PH; Davidson MH Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408 [TBL] [Abstract][Full Text] [Related]
40. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives. Kamaliah MD; Sanjay LD Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]